Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Saltigo Outlines Expansion Plans

February 18, 2008 | A version of this story appeared in Volume 86, Issue 7

Saltigo, the fine chemicals subsidiary of Lanxess, is investing roughly $75 million this year and next to boost the efficiency of its division that supplies the pharmaceutical industry. Pharma accounts for about a quarter of Saltigo's sales; specialty fine chemicals are another quarter, and agrochemicals make up the balance. Last week, Saltigo Managing Director Wolfgang Schmitz opened a $15 million plant in Leverkusen, Germany, fitted to current Good Manufacturing Practice standards and dedicated to the pharma sector. The project effectively recycles a plant built in 1970 that produced dyestuffs from 1970 to 1997 and the drug active ingredient quinolone from 1999 to 2005.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.